<p> Lorne B. Taichman MD, MSc, PhD (631) 375-6604 www.emergingbiotech.com [email protected]</p><p>Professional Appointments Director of Science & Technology (part time), Windham Venture Partners, New York, NY, May 2006 to present  Identify and evaluate early and late stage opportunities for possible investment with a focus on medical devices, diagnostics, drug delivery and pharma research tools.  Engage in scientific due diligence and assist in formulating appropriate development strategy.</p><p>Corporate Associate, Corporate Office of Science and Technology (COSAT), Johnson & Johnson, New Brunswick, NJ, 2000 to 2001 (while on sabbatical leave from Stony Brook University)  Evaluated opportunities in cell/gene therapy, proteomics, metabolomics, ophthalmology, siRNA and other fields for Centocor, Cordis, DePuy, JJR (Australia), J&J Pharmaceutical Research and Development and Therakos.  Worked closely with J&J Development Corporation, the investment arm of J&J.  Explored investment, licensing and funding opportunities with academic investigators and university technology transfer offices.  Reported directly to Corporate Vice President and Chief Scientific Officer of J&J</p><p>Consultant, Corporate Office of Science and Technology (COSAT), Johnson & Johnson, New Brunswick, NJ, 2001 to 2006  Co-chaired COSAT’s cross-company Task Force on Cell Therapy and Regenerative Medicine.  Undertook state-of-science analyses in various therapeutic areas, including diabetes mellitus, cardiac disease, oncology, neurological disorders, orthopedics, and infectious diseases.  Participated as a member of COSAT’s Ophthalmology Task Force and siRNA Task Force.</p><p>Professor Emeritus, Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook University, Stony Brook, NY, 1974 to 2007  Directed an academic research laboratory focused on stem cells, epidermal cell biology and gene therapy.  As principal investigator, secured continuous grant support over a period of 30 years from governmental sources (e.g., NIH), private foundations (e.g., American Cancer Society) and pharmaceutical and cosmetic companies (e.g., J&J, Galderma and Estée Lauder).  Authored more than 65 manuscripts published in peer-reviewed journals.  Participated as an investigator in multi-center NIH-funded program project grants.  Developed unique teaching programs in clinical oral-facial genetics and cutaneous biology.  Co-founder of The Living Skin Bank, a New York State-funded hospital facility for treating burn victims with an autologous cell therapy product.  Served on Institutional Biosafety Committee, University Committee on Conflict of Interest, and Senate Committee on Research.</p><p>Additional Professional and Related Activities  Co-organized First International Workshop on Cutaneous Gene Therapy (NIH 2000) and Papillomavirus Workshop (Cold Spring Harbor Laboratory 1982).  Organized and chaired conference sessions on epithelial gene therapy at Gordon Research Conferences on Epidermal Differentiation and Keratinization.  Adjunct appointments in Departments of Dermatology at Stony Brook University and NYU Medical School.  Licensed to practice medicine in New York State.  Served as expert witness in the field of gene therapy for plaintiff, the prevailing party in patent infringement case.  Visiting Scientist, Papillomavirus Unit, Pasteur Institute, Paris, France (1982-1983).  Proficient in written and spoken French.</p><p>Education 1971 PhD (Molecular Biology) University of Wisconsin, Madison, Wisconsin 1967 MSc (Experimental Pathology) University of Toronto, Toronto, Ontario 1965 MD University of Toronto, Toronto, Ontario</p><p>(References available upon request)</p>